Phenotypic and protein localization heterogeneity associated with AHDC1 pathogenic protein-truncating alleles in Xia-Gibbs syndrome.


Journal

Human mutation
ISSN: 1098-1004
Titre abrégé: Hum Mutat
Pays: United States
ID NLM: 9215429

Informations de publication

Date de publication:
05 2021
Historique:
revised: 01 02 2021
received: 07 09 2020
accepted: 14 02 2021
pubmed: 2 3 2021
medline: 1 4 2022
entrez: 1 3 2021
Statut: ppublish

Résumé

Xia-Gibbs syndrome (XGS) is a rare Mendelian disease typically caused by de novo stop-gain or frameshift mutations in the AT-hook DNA binding motif containing 1 (AHDC1) gene. Patients usually present in early infancy with hypotonia and developmental delay and later exhibit intellectual disability (ID). The overall presentation is variable, however, and the emerging clinical picture is still evolving. A detailed phenotypic analysis of 34 XGS individuals revealed five core phenotypes (delayed motor milestones, speech delay, low muscle tone, ID, and hypotonia) in more than 80% of individuals and an additional 12 features that occurred more variably. Seizures and scoliosis were more frequently associated with truncations that arise before the midpoint of the protein although the occurrence of most features could not be predicted by the mutation position. Transient expression of wild type and different patient truncated AHDC1 protein forms in human cell lines revealed abnormal patterns of nuclear localization including a diffuse distribution of a short truncated form and nucleolar aggregation in mid-protein truncated forms. Overall, both the occurrence of variable phenotypes and the different distribution of the expressed protein reflect the heterogeneity of this syndrome.

Identifiants

pubmed: 33644933
doi: 10.1002/humu.24190
pmc: PMC8115934
mid: NIHMS1692129
doi:

Substances chimiques

AHDC1 protein, human 0
DNA-Binding Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

577-591

Subventions

Organisme : NHGRI NIH HHS
ID : U54 HG006542
Pays : United States
Organisme : NHGRI NIH HHS
ID : K08 HG008986
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA125123
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK056338
Pays : United States
Organisme : NHGRI NIH HHS
ID : UM1 HG008898
Pays : United States
Organisme : NHGRI NIH HHS
ID : UM1 HG006542
Pays : United States
Organisme : NLM NIH HHS
ID : T15 LM007093
Pays : United States

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Am J Med Genet A. 2018 Sep;176(9):1890-1896
pubmed: 30152016
Cold Spring Harb Mol Case Stud. 2015 Oct;1(1):a000562
pubmed: 27148574
Genome Med. 2019 Oct 25;11(1):65
pubmed: 31653223
Cell. 2010 Sep 17;142(6):967-80
pubmed: 20850016
Science. 2017 May 26;356(6340):
pubmed: 28495876
Eur J Obstet Gynecol Reprod Biol. 2020 Jan;244:208-210
pubmed: 31812316
Methods Enzymol. 2013;529:227-40
pubmed: 24011049
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
Nat Genet. 2016 Oct;48(10):1112-8
pubmed: 27618451
Nat Methods. 2013 Aug;10(8):715-21
pubmed: 23900254
Am J Med Genet A. 2018 Jun;176(6):1315-1326
pubmed: 29696776
PLoS Biol. 2010 Feb 16;8(2):e1000312
pubmed: 20169111
Cold Spring Harb Mol Case Stud. 2019 Jun 3;5(3):
pubmed: 30622101
Eur J Med Genet. 2020 Jan;63(1):103637
pubmed: 30858058
Nat Methods. 2016 Mar;13(3):191-2
pubmed: 26914201
Am J Hum Genet. 2014 May 1;94(5):784-9
pubmed: 24791903
Nat Genet. 2013 Jun;45(6):580-5
pubmed: 23715323
Mol Genet Genomic Med. 2019 Apr;7(4):e00596
pubmed: 30729726
Am J Med Genet A. 2021 Mar;185(3):990-994
pubmed: 33372375
FEBS Lett. 2016 Sep;590(17):2927-33
pubmed: 27461740
Iran J Med Sci. 2019 May;44(3):257-261
pubmed: 31182893
Curr Opin Neurobiol. 2007 Feb;17(1):103-11
pubmed: 17275283
Mol Syndromol. 2017 Nov;8(6):308-312
pubmed: 29230160
Biomed Res Int. 2019 Oct 13;2019:5907361
pubmed: 31737670
Mol Syndromol. 2020 Feb;11(1):24-29
pubmed: 32256298

Auteurs

Michael M Khayat (MM)

Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.

He Li (H)

Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.

Varuna Chander (V)

Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.

Jianhong Hu (J)

Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.

Adam W Hansen (AW)

Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.

Shoudong Li (S)

Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.

Josh Traynelis (J)

Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.

Hua Shen (H)

Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.

George Weissenberger (G)

Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.

Fabio Stossi (F)

Integrated Microscopy Core, Advanced Technology Cores, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA.
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA.

Hannah L Johnson (HL)

Integrated Microscopy Core, Advanced Technology Cores, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA.

James R Lupski (JR)

Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Texas Children's Hospital, Houston, Texas, USA.
Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.

Jennifer E Posey (JE)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.

Aniko Sabo (A)

Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.

Qingchang Meng (Q)

Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.

David R Murdock (DR)

Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.

Michael Wangler (M)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Texas Children's Hospital, Houston, Texas, USA.

Richard A Gibbs (RA)

Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH